Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin
Top Cited Papers
- 1 June 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (11), 4198-4200
- https://doi.org/10.1182/blood-2003-10-3471
Abstract
One Japanese pedigree of familial essential thrombocythemia (FET) inherited in an autosomal-dominant manner is presented. A unique point mutation, serine 505 to asparagine 505 (Ser505Asn), was identified in the transmembrane domain of the c-MPL gene in all of the 8 members with thrombocythemia, but in none of the other 8 unaffected members in this FET family. The Ba/F3 cells expressing the mutant Asn505 acquired interleukin 3 (IL-3)-independent survival capacity, whereas those expressing wild-type Ser505 did not. The autonomous phosphorylation of Mek1/2 and Stat5b was observed in the mutant Ba/F3 cells in the absence of IL-3. The former was also found in platelets derived from the affected individual in the absence of thrombopoietin. These results show that the Asn505 is an activating mutation with respect to the intracellular signaling and survival of the cells. This is the first report of FET deriving from a dominant-positive activating mutation of the c-MPL gene. (Blood. 2004;103: 4198-4200)Keywords
This publication has 12 references indexed in Scilit:
- A novel MPL point mutation resulting in thrombopoietin-independent activationLeukemia, 2002
- Lack of Ku80 Alteration in Multiple MyelomaJapanese Journal of Cancer Research, 2002
- Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemiaBlood, 2001
- c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopeniaBlood, 2001
- Compound heterozygosity for two different amino-acid substitution mutations in the thrombopoietin receptor ( c-mpl gene) in congenital amegakaryocytic thrombocytopenia (CAMT)Human Genetics, 2000
- Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopeniaBritish Journal of Haematology, 2000
- Hereditary thrombocythaemia in a Japanese family is caused by a novel point mutation in the thrombopoietin geneBritish Journal of Haematology, 1999
- Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopeniaProceedings of the National Academy of Sciences of the United States of America, 1999
- Proposal for Revised Diagnostic Criteria of Essential Thrombocythemia and Polycythemia Vera by the Thrombocythemia Vera Study GroupSeminars in Thrombosis and Hemostasis, 1997
- A point mutation in the neu oncogene mimics ligand induction of receptor aggregationNature, 1989